First Tracks Biotherapeutics selling stockholders may sell up to 6,106,870 shares of common stock
TRAX•Selling stockholders of First Tracks Biotherapeutics may sell up to 6,106,870 shares of common stock, according to an SEC filing.
1. Share sale filing
Selling stockholders of First Tracks Biotherapeutics may sell up to 6,106,870 shares of common stock, an SEC filing said.
